Grown Rogue International (GRUSF) EPS (Diluted) Growth (5y) (2014 - 2023)
Grown Rogue International (GRUSF) EPS (Diluted) Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -78.91% |
| Jul 31, 2023 | 33.19% |
| Apr 30, 2023 | 66.94% |
| Jan 31, 2023 | 89.55% |
| Aug 31, 2018 | 478.56% |
| Feb 28, 2018 | -10.00% |
| Feb 28, 2017 | 14.87% |
| Nov 30, 2016 | 94.37% |
| Aug 31, 2016 | 130.89% |
| May 31, 2016 | 14.87% |
| Feb 29, 2016 | 95.06% |
| Nov 30, 2015 | 90.23% |
| Feb 28, 2015 | -83.89% |
| Aug 31, 2014 | -36.83% |
| May 31, 2014 | -15.48% |